Meadow Creek Investment Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$3.85M Sell
94,668
-27,216
-22% -$1.15M 0.08% 226
2019
Q2
$5.24M Buy
121,884
+60,900
+100% +$2.34M 0.1% 184
2019
Q1
$2.34M Buy
60,984
+3,332
+6% +$127K 0.05% 301
2018
Q4
$2.04M Buy
57,652
+16,940
+42% +$614K 0.05% 302
2018
Q3
$1.57M Sell
40,712
-2,968
-7% -$104K 0.03% 362
2018
Q2
$1.43M Buy
43,680
+1,736
+4% +$52.4K 0.03% 374
2018
Q1
$1.15M Sell
41,944
-10,724
-20% -$291K 0.02% 388
2017
Q4
$1.31M Sell
52,668
-9,156
-15% -$253K 0.03% 394
2017
Q3
$1.8M Sell
61,824
-126,028
-67% -$3.48M 0.04% 312
2017
Q2
$5.21M Sell
187,852
-102,732
-35% -$2.73M 0.12% 152
2017
Q1
$7.23M Sell
290,584
-42,000
-13% -$1.02M 0.17% 112
2016
Q4
$7.19M Buy
+332,584
New +$7.26M 0.19% 92

Other funds holding BSX

Meadow Creek Investment Management's BSX Position: Q3 2019 in Review

Meadow Creek Investment Management reduced its Boston Scientific (BSX) stake by 22% in Q3 2019, selling an estimated $1.15M and leaving 94,668 shares worth $3.85M. The position accounts for 0.08% of the portfolio, ranked #226.

Meadow Creek Investment Management first reported a position in BSX in Q4 2016 and has held it in 12 quarters since. The position peaked at $7.23M in Q1 2017. 771 funds tracked by Wall St. Rank hold BSX as of Q3 2019.

  • Meadow Creek Investment Management held 94,668 shares of Boston Scientific worth $3.85M as of Q3 2019.
  • Meadow Creek Investment Management sold 27,216 Boston Scientific shares in Q3 2019, an estimated $1.15M.
  • Boston Scientific made up 0.08% of Meadow Creek Investment Management's portfolio in Q3 2019, its #226 holding.
  • Meadow Creek Investment Management first reported a position in Boston Scientific in Q4 2016 and has held it in 12 quarters since.
  • Meadow Creek Investment Management's Boston Scientific position peaked at $7.23M in Q1 2017.
  • 771 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.